The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource. Please follow the citation guidelines if you are using it.
×
TSP48601-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K70650803 TSA199911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 TSA199955-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 TSA199996-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 TSA200037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 TSA200083-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 TSA200125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 TSA200162-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 TSA200195-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 TSF409345-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF409346-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF409347-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF409348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF409350-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSF409349-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF409640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF409644-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF409641-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF409642-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF409643-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF409645-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSF409928-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF409929-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF409930-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF409931-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF409932-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF409933-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSF410221-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF410222-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF410223-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF410224-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF410225-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF410226-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSF410518-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF410519-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF410520-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF410521-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF410522-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF410523-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSF410815-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF410816-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF410817-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF410818-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF410819-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF410820-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSF411109-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF411105-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF411106-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF411107-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF411108-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF411110-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSF411385-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 10.0 µM for 24.0 h 1 subfactor(s) TSF411386-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 3.33 µM for 24.0 h 1 subfactor(s) TSF411387-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 1.11 µM for 24.0 h 1 subfactor(s) TSF411388-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 0.37 µM for 24.0 h 1 subfactor(s) TSF411389-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 0.12 µM for 24.0 h 1 subfactor(s) TSF411390-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 0.04 µM for 24.0 h 1 subfactor(s) TSS409353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS409354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS409355-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS409356-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS409358-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 0.04 µM for 24.0 h TSS409357-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS409648-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS409652-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS409649-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS409650-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS409651-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS409653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K70650803 0.04 µM for 24.0 h TSS409936-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS409937-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS409938-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS409939-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS409940-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS409941-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K70650803 0.04 µM for 24.0 h TSS410229-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS410230-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS410231-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS410232-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS410233-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS410234-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K70650803 0.04 µM for 24.0 h TSS410526-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS410527-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS410528-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS410529-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS410530-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS410531-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K70650803 0.04 µM for 24.0 h TSS410823-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS410824-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS410825-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS410826-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS410827-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS410828-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K70650803 0.04 µM for 24.0 h TSS411117-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS411113-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS411114-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS411115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS411116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS411118-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K70650803 0.04 µM for 24.0 h TSS411393-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 10.0 µM for 24.0 h TSS411394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 3.33 µM for 24.0 h TSS411395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 1.11 µM for 24.0 h TSS411396-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 0.37 µM for 24.0 h TSS411397-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 0.12 µM for 24.0 h TSS411398-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K70650803 0.04 µM for 24.0 h
TSP48601 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K70650803
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided